Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | calcium channel, voltage-dependent, T type, alpha 1G subunit | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_129328 | All targets in OG5_129328 |
Brugia malayi | Voltage-gated calcium channel, T-type, alpha subunit. C. elegans cca-1 ortholog | Get druggable targets OG5_129328 | All targets in OG5_129328 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_129328 | All targets in OG5_129328 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0543 | 0.9724 | 0.9706 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0326 | 0.3303 | 0.5 |
Brugia malayi | Voltage-gated calcium channel, T-type, alpha subunit. C. elegans cca-1 ortholog | 0.0214 | 0 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0552 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0552 | 1 | 1 |
Onchocerca volvulus | 0.0552 | 1 | 0.5 | |
Giardia lamblia | Hypothetical protein | 0.0326 | 0.3303 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0552 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0552 | 1 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0552 | 1 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0552 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0543 | 0.9724 | 0.9724 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.3028 | 0.3028 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0543 | 0.9724 | 0.9706 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0552 | 1 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0326 | 0.3303 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0326 | 0.3303 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0543 | 0.9724 | 0.9706 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0326 | 0.3303 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0543 | 0.9724 | 0.9706 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.631 | Inhibition of human T-type calcium channel alpha1G in HEK293 cells | ChEMBL. | 19951839 |
IC50 (functional) | = 2.5 uM | Concentration of the compounds required for inhibition of HEK293 cells (alpha1G T-type) | ChEMBL. | 15177437 |
IC50 (functional) | = 2.5 uM | Concentration of the compounds required for inhibition of HEK293 cells (alpha1G T-type) | ChEMBL. | 15177437 |
Inhibition (functional) | = 32.2 % | Inhibition of HVA N-type [Ca2+] channels of major pelvic ganglion (MPG) neurons at 10 uM | ChEMBL. | 15177437 |
Inhibition (functional) | = 32.2 % | Inhibition of HVA N-type [Ca2+] channels of major pelvic ganglion (MPG) neurons at 10 uM | ChEMBL. | 15177437 |
Inhibition (functional) | = 37.7 % | Inhibition of LVA T-type [Ca2+] channels of major pelvic ganglion (MPG) neurons at 10 uM | ChEMBL. | 15177437 |
Inhibition (functional) | = 91.9 % | In vitro inhibitory effect on alpha1H T-type [Ca2+] channels expressed in Xenopus oocytes at 100 microM | ChEMBL. | 15177437 |
Inhibition (functional) | = 91.9 % | In vitro inhibitory effect on alpha1H T-type [Ca2+] channels expressed in Xenopus oocytes at 100 microM | ChEMBL. | 15177437 |
Inhibition (functional) | = 92.3 % | In vitro inhibition of alpha1G T-type [Ca2+] channels expressed in HEK293 cells at 10 uM | ChEMBL. | 15177437 |
Inhibition (functional) | = 92.3 % | In vitro inhibition of alpha1G T-type [Ca2+] channels expressed in HEK293 cells at 10 uM | ChEMBL. | 15177437 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.